Table 2. Survival data.
| Variable | Univariate | Multivariate | ||
|---|---|---|---|---|
| HR (95%CI) | p | HR (95%CI) | p | |
| NCCN prognostic group: | 2.72 (2.00-3.78) | <0.001 | 1.92 (1.40-2.69) | <0.001 |
| •intermediate/good | 2.01 (1.71-2.35) | <0.001 | 2.01 (1.71-2.37) | <0.001 |
| •poor/intermediate | ||||
| Age>60 | 2.13 (1.83-2.48) | <0.001 | 1.53 (1.30-1.81) | <0.001 |
| PS>1 | 1.80 (1.49-2.16) | <0.001 | 1.56 (1.28-1.89) | <0.001 |
| CD34>median | 1.23 (1.06-1.42) | 0.005 | 1.07 (0.91-1.25) | 0.379 |
| Male gender | 1.02 (0.88-1.18) | 0.779 | 1.00 (0.86-1.17) | 0.952 |
| Year of Diagnosis | 1.13 (0.96-1.33) | 0.12 | 1.08 (0.91-1.28) | 0.359 |
| •2000-2003/2004-2008 | 1.34 (1.09-1.66) | <0.001 | 1.22 (0.97-1.53) | 0.07 |
| •2004-2008/2009-2012 | ||||
| Response to treatment | 7.47 (5.22-10.44) | <0.001 | 6.97 (4.69-10.06) | <0.001 |
| •Died/poor | 3.17 (2.7-3.72) | <0.001 | 2.35 (1.97-2.80) | <0.001 |
| •Poor/complete | ||||
| CCBs | 1.6 (1.22-2.06) | <0.001 | 1.39(1.05-1.80) | 0.02 |